Genentech is Broadway bound with latest campaign to raise spinal muscular atrophy awareness
Genentech is taking its spinal muscular atrophy awareness efforts to New York with an original musical comedy. The show, called “Most Likely Not To…” will be performed on Feb. 29, also known as Rare Disease Day, with a cast that includes actors, writers and performers with SMA.
Created in consultation with the SMA community, the show focuses on a woman living with SMA who wins a raffle to attend her 20-year high school reunion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.